HSCB £4.75m Community Pharmacy Staff Funding Allocation Letter –
October 2020
Summary
Mr Joe Brogan, HSCB has issued a letter COVID-19: Community
Pharmacy Funding for Staff Pressures by secure email to community
pharmacies across Northern Ireland. The letter relates to £4.75m funding being
provided to Contractors in respect of additional staffing pressures that
community pharmacies face due to COVID-19 and it is part of the £13.25m
Community Pharmacy funding allocation that was announced by Mr Robin Swann,
Minister for Health on 1st July 2020.
The letter, sent by secure email to each pharmacy, states the
amount of funding that is allocated to the recipient pharmacy.
You will see from the attached template HSCB letter that Contractors
are required to complete and return a Community Pharmacy Funding Staff
Pressures Declaration (Appendix A) to HSCB offices by Tuesday 10th
November 2020 for the funding to be released and paid by the BSO.
If you operate more than one pharmacy a separate declaration has
to be submitted for each pharmacy contract.
Action
In order to avail of the funding Contractors should:-
Obtain a copy of the letter that has been issued by
secure email to each pharmacy you operate.
Note the funding allocation being made available by
HSCB to each pharmacy you operate.
Consider the steps you will have to undertake in order
for the funding to be released to the pharmacy(-ies) you operate, noting
in particular the Declaration (Appendix A) return date of Tuesday 10th
November 2020
Note that you will be required to submit information to
HSCB at a later date as part of an assurance process, similar to the HSCB
assurance process that you were asked to complete in June 2020 for the
funding provided previously for staff and premises modifications.
CPNI will provide you with additional information w/c 2nd
November 2020 to assist you further in this matter further.
In the event that you cannot access the secure email account(s)
associated with the pharmacy(-ies) you operate please contact your local HSCB
office who will be able to provide you with details of the funding being
provided.
It is anticipated that the funding will be paid by BSO at the
end of November to pharmacies that return the declaration by 10th
November 2020.
The release of this funding is positive and to be welcomed. It
will assist you and your pharmacy teams in the coming weeks and months to
continue providing important and highly valued community pharmacy services to
your patients during the COVID pandemic.
If you have queries in relation to the letter please contact your local HSCB office or the CPNI office.
Contact Details for Local Integrated Care Offices:
I trust this is helpful.
Yours sincerely
SENT
FOR AND BEHALF OF GERARD GREENE | Chief Executive
Please find attached for your urgent attention, correspondence
from Donna Scott, Head of Counter Fraud and Probity, BSO.
Please bring this to the attention of the pharmacists in your
dispensary teams.
Yours sincerely
SENT
FOR AND BEHALF OF GERARD GREENE | Chief Executive
Download
Dear Contractor
HSCB
CORRESPONDENCE: ARRANGEMENTS FOR THE MANAGEMENT OF REPEAT PRESCRIPTION REQUESTS
Mr Joe
Brogan, HSCB has issued the attached letter and HSCB Repeat Prescription
Management (COVID 19 Pandemic) guidance document for Community Pharmacists
and GP Practices in relation to the management of repeat prescription requests.
Summary
The HSCB Guidance
document provides important information on several aspects associated with
repeat prescription requests during COVID-19 and it includes guidance on,
amongst other aspects, the ordering of repeat prescriptions, the collection of
prescriptions from GP practices, the transfer of urgent prescriptions,
prescribing intervals and guidance on the quantities of medicines being
prescribed.
The information
contained in the guidance document builds on the experience and lessons learned
about prescription processes from the first wave of COVID-19 and the guidance
will be important to help Community Pharmacy and GP teams manage repeat
prescription processes as we enter the next wave of COVID-19.
Action
Contractors should:
Note the content of this
letter and the accompanying HSCB Guidance document entitled Repeat
Prescription Management (COVID 19 Pandemic); and
Ensure that the letter and
HSCB Guidance document is considered by all members of your pharmacy teams
involved in the management of repeat prescriptions and associated
processes.
Local engagement
with GP’s and practice staff should also be considered to assist in the smooth
implementation of the HSCB guidance for the benefit of patients and to
streamline and further enhance the inter-professional working between Community
Pharmacy and GP teams over the coming weeks and months.
As always, should you require any additional information in relation to the HSCB letter or Guidance document please do not hesitate to contact, in the first instance, your local HSCB Pharmacy office, details of which are provided below.
Contact Details for Local Integrated Care Offices:
Yours sincerely
SENT
FOR AND BEHALF OF GERARD GREENE | Chief Executive
Download
Dear Contractor
THE
HUMAN MEDICINES (CORONAVIRUS AND INFLUENZA) (AMENDMENT) REGULATIONS 2020:
AMENDMENTS TO THE HUMAN MEDICINES REGULATIONS 2012
The
Department of Health has issued a letter (attached) confirming that amendments have been made to the Human Medicines
Regulations 2012 to support the rapid and
effective rollout of a
COVID-19 vaccine and the influenza (flu) vaccine in the UK.
Summary
The amendments
cover a range of issues including those relating to temporary licensing,
increasing the scope of civil immunity, increasing the range of personnel
permitted to administer the vaccines, and wholesale dealing and promotion of
the vaccines.
Action
Contractors should:
Note the content of this
letter; and
Be aware that further
notifications on operational aspects will be issued.
As further
information on these matters is provided by the Department, CPNI will continue
to keep contractors informed and supported.
Kind regards
Mike
Sent on behalf of Prof Mike Mawhinney | Head of Regulatory Affairs
Download
Dear Colleague
REMINDER – CONTINUED USE OF URGENT PANDEMIC PACKS IN NURSING
HOMES IN NORTHERN IRELAND
Please find attached for your information, correspondence from
Joe Brogan, Head of Pharmacy and Medicines Management
and Dr.
Margaret O’Brien, Assistant Director of Integrated Care, Head of General
Medical Services (GMS).
Yours sincerely
SENT
FOR AND BEHALF OF GERARD GREENE | Chief Executive
Download
Dear Colleague,
Please find attached agenda for the Echo session that is
scheduled to take place on Tuesday 27th October 2020.
Topics covered will include the Community Pharmacy Business Continuity
Arrangements, Pharmacy First for Colds and Sore Throats and the Adherence
Support Service.
Please use the meeting ID and passcode below to access the meeting:
Meeting ID: 663 219 8075
Passcode: 678281
Please also find attached Attendee/Moodle Guidance Notes and
Project ECHO Enhanced Security Measures for newly registered participants.
I would encourage Contractors and pharmacist team members to attend
this Echo session where possible.
Yours sincerely
SENT FOR AND BEHALF
OF GERARD GREENE | Chief Executive
Download
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
